Andrea Ellis
Director at BridgeBio Pharma, Inc. (BBIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 13SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 17,16722,579 held (−43%) | $84.00 | $1.4M | -21.0% |
| Mar 6SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 64,92118,589 held (−78%) | $64.87 | $4.2M | +2.3% |
- Sell
Director Andrea Ellis sold $1.4M of BBIO at $84.00 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Andrea Ellis sold $4.2M of BBIO at $64.87 — cuts the stake by 78%; pre-scheduled 10b5-1 plan sale.